Market revenue in 2024 | USD 843.9 million |
Market revenue in 2030 | USD 1,211.1 million |
Growth rate | 6.2% (CAGR from 2024 to 2030) |
Largest segment | Consumables |
Fastest growing segment | Rapid Testing Devices |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments, Rapid Testing Devices, Services |
Key market players worldwide | Quest Diagnostics Inc, Abbott Laboratories, QuidelOrtho Corp, Roche Holding AG ADR, Thermo Fisher Scientific Inc, Siemens Healthineers AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Labcorp Holdings Inc, Clinical Reference Laboratory, Cordant Health Solutions, Legacy Medical, Draegerwerk AG & Co KGaA, Omega Laboratories |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug testing market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 34.62% in 2024. Horizon Databook has segmented the UK drug testing market based on consumables, instruments, rapid testing devices, services covering the revenue growth of each sub-segment from 2018 to 2030.
In the UK, drug testing is a common practice in safety-critical industries such as transportation, construction, and healthcare. The legal framework for drug testing in the UK is influenced by employment law, with employers generally implementing testing policies to ensure workplace safety and productivity.
Furthermore, the government is focusing on substantial investments to control drug abuse.Government authorities are focusing on controlling deaths caused due to drug addiction and overdose. Moreover, in September 2022, Medical Research Council allotted funding of USD 3.13 million for study of cannabis on the human brain.
Horizon Databook provides a detailed overview of country-level data and insights on the UK drug testing market , including forecasts for subscribers. This country databook contains high-level insights into UK drug testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account